In Depth 10 Mar 2021
Can Gene Therapy Cure Blindness?
Since the approval of the first gene therapy for blindness, there has been a wave of companies developing gene therapy…
Editas Medicine
- Latest Posts
In Depth 11 Feb 2019
CRISPR: One Patent to Rule Them All
The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for the rights to the technology’s…
News and Trends 15 Mar 2017
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
Allergan has signed a deal with Editas Medicine to access its CRISPR technology and license up to five of its…
News and Trends 16 Feb 2017
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
The US Patent Office has ruled that the Broad Institute's CRISPR patents do not interfere with those from UC Berkeley.…
ADVERTISEMENT
News and Trends 8 Dec 2016
UPDATE: No Clear Winner in the CRISPR Patent Battle
Today marks an inflection point in the future of medicine: both parties fighting for the ownership of CRISPR have made…
News and Trends 15 Nov 2016
How much of a Gamble is Investing in CRISPR?
CRISPR is going to change a lot in the life science industry and is perceived as THE discovery of the…
News and Trends 12 Sep 2016
CRISPR Therapeutics applies to go Public in another Massive IPO
The wait is over: CRISPR Therapeutics has turned up the heat on its rivals with an IPO filing of €80M, but…
News and Trends 5 Jul 2016
“CRISPR is highly fragmented, with too many approaches. We bring it all together”
The problem with CRISPR, is that not many people are actually experts in the field, and there are only a select…
News and Trends 30 Sep 2015
CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?
CRISPR is already revolutionizing Biotechnology. However, like every biotech revolution, there then follows a patent war. But the discovery of…
News and Trends 16 Sep 2015
Desktop Genetics bags €1.87M from top UK business angels to change how you manage your CRIPSR experiments
Gene Editing has been made much easier thanks to CRISPR but managing your genome editing workflow can be a challenge. London-based…
News and Trends 12 Aug 2015
CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey
A new strategic movement in the hot CRISPR field: CRISPR Therapeutics ramps up its leadership team with Samarth Kulkarni as…
News and Trends 18 Jun 2015
German Viral Vector Producer SIRION pursues its American dream and opens in Boston
The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its…
News and Trends 8 Apr 2015
CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War
CRISPR Therapeutics appointed Bill Lundberg to Chief Scientific Officer to lead the company’s development programs and to spearhead the creation…
News and Trends 10 Mar 2015
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and…
News and Trends 21 Jan 2015
Review: The CRISPR’s Therapeutical revolution
Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex CRISPR-Cas9 (CRISPR, clustered regularly interspaced…
